Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Early Toxicity Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global early toxicity testing market reached a value of US$ 1.08 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1.79 Billion by 2027, exhibiting a CAGR of 8.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Early toxicity testing of new compounds is used to develop drugs and the extension of the therapeutic potential of existing molecules. It is carried out at pre-clinical stages on various biological systems to investigate the species, organs, and dose-specific toxic effects of a product. It can be performed in multiple ways, including in vivo on animals, in vitro in laboratories using assays, and in silico on a computer. It is also utilized for studying accidental exposures to a substance. Nowadays, the high-cost impact of late-stage failures of drug candidates is encouraging pharma companies to conduct early toxicity testing on investigational products.

Early Toxicity Testing Market Trends:

Exposure to toxic chemicals occurs through skin contact, oral intake, or inhalation. Therefore, early toxicity testing has become a crucial process in various industrial applications for determining the degree of toxicity in products and ensuring that they are safe for human consumption and the environment. For example, it is extensively utilized in the food and beverage (F&B) industry to identify the adverse effects and characterize potential toxicants in products. Moreover, the rising prevalence of diseases and the requirement of novel drugs and biological products are encouraging the adoption of early toxicity testing to prevent the failure of candidate drugs at clinical trials. In addition, stringent regulations relating to public health welfare imposed by regulatory authorities are positively influencing the demand for early toxicity testing to determine the viability of drugs required for regulatory approval. Apart from this, the increasing usage of pesticides can pose risks to human health, which is promoting the use of early toxicity testing in the agriculture industry. Furthermore, the escalating demand for cosmetic products is expanding the application of early toxicity testing of cosmetic ingredients worldwide.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global early toxicity testing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technique and end user.

Breakup by Technique:

  • In Vivo
  • In Vitro
  • In Silico
     

Breakup by End User:

  • Pharmaceuticals Industry
  • Food Industry
  • Chemicals Industry
  • Cosmetics Industry
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, Evotec A.G., Merck KGaA, PerkinElmer Inc., SGS S.A., Thermo Fisher Scientific Inc. and WuXi AppTec.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Technique, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, Evotec A.G., Merck KGaA, PerkinElmer Inc., SGS S.A., Thermo Fisher Scientific Inc. and WuXi AppTec.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global early toxicity testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global early toxicity testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technique?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global early toxicity testing market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Early Toxicity Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Technique
    6.1    In Vivo
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    In Vitro
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    In Silico
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by End User
    7.1    Pharmaceuticals Industry
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Food Industry
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Chemicals Industry
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Cosmetics Industry
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Agilent Technologies Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Bio-Rad Laboratories Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Bruker Corporation
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Charles River Laboratories International Inc.
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    Danaher Corporation
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
        13.3.6    Enzo Biochem Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
           13.3.6.4 SWOT Analysis
        13.3.7    Eurofins Scientific SE
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Evotec A.G.
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Merck KGaA
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
        13.3.10    PerkinElmer Inc.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
        13.3.11    SGS S.A.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio
           13.3.11.3 Financials
        13.3.12    Thermo Fisher Scientific Inc.
           13.3.12.1 Company Overview
           13.3.12.2 Product Portfolio
           13.3.12.3 Financials
           13.3.12.4 SWOT Analysis
        13.3.13    WuXi AppTec
           13.3.13.1 Company Overview
           13.3.13.2 Product Portfolio
           13.3.13.3 Financials

List of Figures

Figure 1: Global: Early Toxicity Testing Market: Major Drivers and Challenges
Figure 2: Global: Early Toxicity Testing Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Early Toxicity Testing Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Early Toxicity Testing Market: Breakup by Technique (in %), 2021
Figure 5: Global: Early Toxicity Testing Market: Breakup by End User (in %), 2021
Figure 6: Global: Early Toxicity Testing Market: Breakup by Region (in %), 2021
Figure 7: Global: Early Toxicity Testing (In Vivo) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Early Toxicity Testing (In Vivo) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Early Toxicity Testing (In Vitro) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Early Toxicity Testing (In Vitro) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Early Toxicity Testing (In Silico) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Early Toxicity Testing (In Silico) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Early Toxicity Testing (Food Industry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Early Toxicity Testing (Food Industry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Early Toxicity Testing (Chemicals Industry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Early Toxicity Testing (Chemicals Industry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Early Toxicity Testing (Cosmetics Industry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Early Toxicity Testing (Cosmetics Industry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Early Toxicity Testing (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Early Toxicity Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: North America: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: North America: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: United States: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: United States: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Canada: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Canada: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Asia-Pacific: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Asia-Pacific: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: China: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: China: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Japan: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Japan: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: India: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: India: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: South Korea: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: South Korea: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Australia: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Australia: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Indonesia: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Indonesia: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Others: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Europe: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Europe: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Germany: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Germany: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: France: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: France: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: United Kingdom: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: United Kingdom: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Italy: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Italy: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Spain: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Spain: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Russia: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Russia: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Latin America: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Latin America: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Brazil: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Brazil: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Mexico: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Mexico: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Middle East and Africa: Early Toxicity Testing Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Middle East and Africa: Early Toxicity Testing Market: Breakup by Country (in %), 2021
Figure 71: Middle East and Africa: Early Toxicity Testing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Global: Early Toxicity Testing Industry: SWOT Analysis
Figure 73: Global: Early Toxicity Testing Industry: Value Chain Analysis
Figure 74: Global: Early Toxicity Testing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Early Toxicity Testing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Early Toxicity Testing Market Forecast: Breakup by Technique (in Million US$), 2022-2027
Table 3: Global: Early Toxicity Testing Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 4: Global: Early Toxicity Testing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Early Toxicity Testing Market: Competitive Structure
Table 6: Global: Early Toxicity Testing Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links